CALCHEK T 40

AboutCALCHEK T 40 contains Telmisartan 40mg, an Angiotensin Receptor Blocker (ARB) widely used for the treatment of essential hypertension and cardiovascular risk reduction. Telmisartan works by selectively blocking the binding of angiotensin II to the AT1 receptor in various tissues, including vascular smooth muscle and the adrenal gland. This blockade prevents the vasoconstrictive and aldosterone-secreting effects of angiotensin II, leading to vasodilation, decreased peripheral vascular resistance, and a reduction in blood pressure. Telmisartan has a long duration of action, allowing for once-daily dosing, which contributes to better patient adherence. Beyond its antihypertensive effects, Telmisartan has demonstrated benefits in reducing the risk of cardiovascular morbidity and mortality in high-risk patients, such as those with established cardiovascular disease or type 2 diabetes with end-organ damage. It is a well-tolerated alternative for patients who cannot tolerate ACE inhibitors.UsesTreatment of essential hypertensionReduction of cardiovascular morbidity and mortality in high-risk patientsManagement of diabetic nephropathy (off-label use)Prevention of stroke and myocardial infarctionDirections For UseTake one tablet orally once daily, with or without food, as prescribed by your doctor.BenefitsProvides effective and sustained blood pressure controlOffers significant cardiovascular protectionWell-tolerated with a low incidence of coughConvenient once-daily dosing regimenMay have renal protective effects in diabetic patientsReduces the risk of stroke and heart attackSide EffectsDizziness or lightheadednessHeadacheFatigue or weaknessLow blood pressure (hypotension)Hyperkalemia (elevated potassium levels)Kidney dysfunction or increased creatinineBack painDiarrhea or nauseaUpper respiratory tract infectionMuscle cramps or painAngioedema (rare)InsomniaSafety MeasuresAlcohol - Alcohol may enhance the hypotensive effect and increase the risk of dizziness. Use with caution.Pregnancy - Contraindicated during the second and third trimesters due to potential fetal harm and toxicity.Breastfeeding - Not recommended during breastfeeding as it may pass into breast milk. Consult a doctor.Liver - Use with caution in patients with severe hepatic impairment; dose adjustment may be needed.Kidney - Use with caution in renal impairment; monitor kidney function closely, especially in severe cases.Lung - Generally safe; no specific lung-related contraindications or adverse effects are commonly associated.DisclaimerMedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.Our goal is to complement, not replace, the essential doctor-patient relationship.